Prime Medicine Inc — Cash Flow (NASDAQ:PRME) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 131.83 M165.41 M122.86 M 109.06 M Cash from investing activities 47.1 M18.71 M68.46 M 185.35 M Cash from financing activities 181.49 M655 K195.88 M 150.95 M Free cash flow 115.73 M156.69 M115.57 M 103.03 M

뉴스

Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates

프라임 드링크 그룹, 사모 배치 1차 마감 완료

Prime Drink Group completes first closing of private placement

Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond

프라임 드링크 그룹, 최대 5백만 달러 규모의 사모 발행 발표

Prime Drink Group announces private placement to raise up to $5 million

골드만삭스, 프라임 메디슨에 ’초기 바이오’ 등급 재확인

Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock

Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates

Prime Medicine appoints Matthew Hawryluk as chief business officer

NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates

Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)